Hellstrom KE - Search Results

1

Mesothelin variant 1 is released from tumor cells as a diagnostic marker.

Hellstrom I, Raycraft J, Kanan S, Sardesai NY, Verch T, Yang Y, Hellstrom KE. Hellstrom I, et al. Among authors: hellstrom ke. Cancer Epidemiol Biomarkers Prev. 2006 May;15(5):1014-20. doi: 10.1158/1055-9965.EPI-05-0334. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16702385

2

SMRP and HE4 as biomarkers for ovarian carcinoma when used alone and in combination with CA125 and/or each other.

Hellstrom I, Hellstrom KE. Hellstrom I, et al. Among authors: hellstrom ke. Adv Exp Med Biol. 2008;622:15-21. doi: 10.1007/978-0-387-68969-2_2. Adv Exp Med Biol. 2008. PMID: 18546615 Review.

3

Anti-mesothelin antibodies and circulating mesothelin relate to the clinical state in ovarian cancer patients.

Hellstrom I, Friedman E, Verch T, Yang Y, Korach J, Jaffar J, Swisher E, Zhang B, Ben-Baruch G, Tan MC, Goedegebuure P, Hellstrom KE. Hellstrom I, et al. Among authors: hellstrom ke. Cancer Epidemiol Biomarkers Prev. 2008 Jun;17(6):1520-6. doi: 10.1158/1055-9965.EPI-08-0039. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18559570

4

Therapeutic vaccination with tumor cells that engage CD137.

Hellstrom KE, Hellstrom I. Hellstrom KE, et al. Among authors: hellstrom i. J Mol Med (Berl). 2003 Feb;81(2):71-86. doi: 10.1007/s00109-002-0413-8. Epub 2003 Feb 8. J Mol Med (Berl). 2003. PMID: 12601523 Review.

5

The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma.

Hellström I, Raycraft J, Hayden-Ledbetter M, Ledbetter JA, Schummer M, McIntosh M, Drescher C, Urban N, Hellström KE. Hellström I, et al. Among authors: hellstrom ke. Cancer Res. 2003 Jul 1;63(13):3695-700. Cancer Res. 2003. PMID: 12839961

6

Melanoma cells transfected to express CD83 induce antitumor immunity that can be increased by also engaging CD137.

Yang S, Yang Y, Raycraft J, Zhang H, Kanan S, Guo Y, Ronai Z, Hellstrom I, Hellstrom KE. Yang S, et al. Among authors: hellstrom i, hellstrom ke. Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):4990-5. doi: 10.1073/pnas.0400880101. Epub 2004 Mar 29. Proc Natl Acad Sci U S A. 2004. PMID: 15051893 Free PMC article.

7

Soluble mesothelin-related protein--a blood test for mesothelioma.

Robinson BW, Creaney J, Lake R, Nowak A, Musk AW, de Klerk N, Winzell P, Hellstrom KE, Hellstrom I. Robinson BW, et al. Among authors: hellstrom i, hellstrom ke. Lung Cancer. 2005 Jul;49 Suppl 1:S109-11. doi: 10.1016/j.lungcan.2005.03.020. Lung Cancer. 2005. PMID: 15950789

8

Effect of adenovirus-mediated heat shock protein expression and oncolysis in combination with low-dose cyclophosphamide treatment on antitumor immune responses.

Di Paolo NC, Tuve S, Ni S, Hellström KE, Hellström I, Lieber A. Di Paolo NC, et al. Among authors: hellstrom i, hellstrom ke. Cancer Res. 2006 Jan 15;66(2):960-9. doi: 10.1158/0008-5472.CAN-05-2388. Cancer Res. 2006. PMID: 16424031 Free PMC article.

9

Tumor cells expressing anti-CD137 scFv induce a tumor-destructive environment.

Yang Y, Yang S, Ye Z, Jaffar J, Zhou Y, Cutter E, Lieber A, Hellström I, Hellström KE. Yang Y, et al. Among authors: hellstrom i, hellstrom ke. Cancer Res. 2007 Mar 1;67(5):2339-44. doi: 10.1158/0008-5472.CAN-06-3593. Cancer Res. 2007. PMID: 17332366

10

Vaccines to treat cancer--an old approach whose time has arrived.

Hellstrom KE, Hellstrom I. Hellstrom KE, et al. Among authors: hellstrom i. J Cell Biochem. 2007 Oct 1;102(2):291-300. doi: 10.1002/jcb.21468. J Cell Biochem. 2007. PMID: 17729239 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

380 results

Search Page